Trials / Completed
CompletedNCT02669771
Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
Xtandi® Capsules 40 mg Protocol for Long-Term Specified Drug Use-Results Survey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,018 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the long term safety and efficacy of enzalutamide in patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | enzalutamide | oral |
Timeline
- Start date
- 2014-11-30
- Primary completion
- 2018-11-30
- Completion
- 2018-11-30
- First posted
- 2016-02-01
- Last updated
- 2024-11-21
Locations
47 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02669771. Inclusion in this directory is not an endorsement.